Haemonetics SG&A Expenses 2010-2024 | HAE

Haemonetics sg&a expenses from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
Haemonetics Annual SG&A Expenses
(Millions of US $)
2024 $432
2023 $377
2022 $340
2021 $275
2020 $282
2019 $273
2018 $317
2017 $302
2016 $317
2015 $337
2014 $366
2013 $323
2012 $244
2011 $214
2010 $214
2009 $199
Haemonetics Quarterly SG&A Expenses
(Millions of US $)
2024-12-31 $106
2024-09-30 $107
2024-06-30 $108
2024-03-31 $111
2023-12-31 $112
2023-09-30 $115
2023-06-30 $93
2023-03-31 $98
2022-12-31 $95
2022-09-30 $92
2022-06-30 $92
2022-03-31 $92
2021-12-31 $81
2021-09-30 $76
2021-06-30 $91
2021-03-31 $84
2020-12-31 $66
2020-09-30 $64
2020-06-30 $62
2020-03-31 $53
2019-12-31 $78
2019-09-30 $78
2019-06-30 $73
2019-03-31 $54
2018-12-31 $74
2018-09-30 $77
2018-06-30 $69
2018-03-31 $79
2017-12-31 $98
2017-09-30 $73
2017-06-30 $67
2017-03-31 $72
2016-12-31 $71
2016-09-30 $71
2016-06-30 $88
2016-03-31 $76
2015-12-31 $79
2015-09-30 $75
2015-06-30 $88
2015-03-31 $77
2014-12-31 $83
2014-09-30 $85
2014-06-30 $93
2014-03-31 $88
2013-12-31 $90
2013-09-30 $82
2013-06-30 $107
2013-03-31 $88
2012-12-31 $87
2012-09-30 $81
2012-06-30 $68
2012-03-31 $63
2011-12-31 $61
2011-09-30 $63
2011-06-30 $56
2011-03-31 $50
2010-12-31 $57
2010-09-30 $53
2010-06-30 $54
2010-03-31 $64
2009-12-31 $53
2009-09-30 $47
2009-06-30 $50
2009-03-31 $57
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.198B $1.309B
Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $229.174B 28.29
Boston Scientific (BSX) United States $155.945B 42.10
Stryker (SYK) United States $148.251B 31.87
EssilorLuxottica (ESLOY) France $140.098B 0.00
Medtronic (MDT) Ireland $111.559B 16.29
Lonza Group Ag (LZAGY) Switzerland $46.232B 0.00
Haleon (HLN) United Kingdom $45.180B 29.35
GE HealthCare Technologies (GEHC) United States $42.309B 20.61
Agilent Technologies (A) United States $39.127B 25.93
ResMed (RMD) United States $34.442B 26.53
Terumo (TRUMY) Japan $26.591B 37.81
Koninklijke Philips (PHG) Netherlands $23.545B 16.81
Zimmer Biomet Holdings (ZBH) United States $20.572B 12.92
Insulet (PODD) United States $19.899B 79.24
Baxter (BAX) United States $15.736B 10.24
Sunny Optical Technology (SNPTF) China $11.331B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $11.201B 0.00
BellRing Brands (BRBR) United States $9.927B 37.20
Demant (WILYY) Denmark $7.946B 0.00
Bio-Rad Laboratories (BIO) United States $7.944B 27.52
Lantheus Holdings (LNTH) United States $5.659B 13.15
Prestige Consumer Healthcare (PBH) United States $4.205B 20.07
ICU Medical (ICUI) United States $4.019B 38.26
Envista Holdings (NVST) United States $3.747B 29.81
Perrigo (PRGO) Ireland $3.383B 9.96
Shandong Weigao Medical Polymer (SHWGF) China $2.989B 0.00
GN Store Nord (GNNDY) Denmark $2.913B 19.63
QuidelOrtho (QDEL) United States $2.817B 23.67
LeMaitre Vascular (LMAT) United States $2.319B 56.37
Neogen (NEOG) United States $2.232B 25.73
AtriCure (ATRC) United States $1.907B 0.00
Green Thumb Industries (GTBIF) United States $1.484B 25.89
InMode (INMD) Israel $1.349B 11.28
BioLife Solutions (BLFS) United States $1.296B 0.00
AdaptHealth (AHCO) United States $1.211B 8.65
Maravai LifeSciences Holdings (MRVI) United States $1.030B 0.00
Phibro Animal Health (PAHC) United States $0.979B 15.01
Evolus (EOLS) United States $0.942B 0.00
Curaleaf Holdings (CURLF) Canada $0.918B 0.00
CeriBell (CBLL) United States $0.794B 0.00
Capricor Therapeutics (CAPR) United States $0.686B 0.00
Valneva SE (VALN) France $0.613B 0.00
Omeros (OMER) United States $0.536B 0.00
VAREX IMAGING (VREX) United States $0.529B 22.95
Owens & Minor (OMI) United States $0.527B 4.12
Surmodics (SRDX) United States $0.491B 0.00
SNDL (SNDL) Canada $0.465B 0.00
Cresco Labs (CRLBF) United States $0.438B 0.00
ZimVie (ZIMV) United States $0.368B 31.00
SEMPERIT AG HLD (SEIGY) Austria $0.349B 0.00
Verano Holdings (VRNOF) United States $0.341B 0.00
Cerus (CERS) United States $0.336B 0.00
Aurora Cannabis (ACB) Canada $0.318B 57.90
Viemed Healthcare (VMD) United States $0.315B 30.00
Sanara MedTech (SMTI) United States $0.309B 0.00
Quanterix (QTRX) United States $0.301B 0.00
OraSure Technologies (OSUR) United States $0.294B 19.70
Biote (BTMD) United States $0.266B 5.83
Canopy Growth (CGC) Canada $0.260B 0.00
Zynex (ZYXI) United States $0.239B 50.13
Sanuwave Health (SNWV) United States $0.236B 3.31
Brainsway (BWAY) Israel $0.213B 113.20
High Tide (HITI) Canada $0.210B 0.00
Utah Medical Products (UTMD) United States $0.206B 15.40
MacroGenics (MGNX) United States $0.183B 0.00
TriSalus Life Sciences (TLSI) United States $0.174B 0.00
Organigram Holdings (OGI) Canada $0.167B 0.00
TerrAscend (TSNDF) Canada $0.147B 0.00
FitLife Brands (FTLF) United States $0.141B 17.65
Jin Medical (ZJYL) China $0.122B 0.00
Quipt Home Medical (QIPT) United States $0.115B 0.00
Fonar (FONR) United States $0.095B 13.08
Oramed Pharmaceuticals (ORMP) United States $0.094B 0.00
Veru (VERU) United States $0.088B 0.00
InterCure (INCR) Israel $0.073B 0.00
Exagen (XGN) United States $0.068B 0.00
Jushi Holdings (JUSHF) United States $0.068B 0.00
Cytosorbents (CTSO) United States $0.067B 0.00
Rockwell Medical (RMTI) United States $0.060B 30.83
Apyx Medical (APYX) United States $0.056B 0.00
MariMed (MRMD) United States $0.052B 0.00
Hongchang (HCIL) China $0.051B 0.00
United-Guardian (UG) United States $0.049B 14.17
ImmuCell (ICCC) United States $0.046B 0.00
INLIF (INLF) $0.046B 0.00
Modular Medical (MODD) United States $0.045B 0.00
Safety Shot (SHOT) United States $0.031B 0.00
Nephros (NEPH) United States $0.016B 0.00
Cellectar Biosciences (CLRB) United States $0.015B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Innovative Eyewear (LUCY) United States $0.011B 0.00
Allurion Technologies (ALUR) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.009B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Agape ATP (ATPC) $0.004B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Sharps Technology (STSS) United States $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00